Skip to main content

WELLS FARGO & COMPANY/MN

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 72971 SAN FRANCISCO, CA

Position in FULC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$181,887
+$8,921 QoQ
Shares Held
49,696
+120.4% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 154 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FULC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. FULC ranks #255 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FULC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $181,887 49,696
2026-03-31 $172,966 22,551
2025-12-31 $1,881,927 166,395
2025-09-30 $299,064 32,507
2025-06-30 $232,186 33,748
2025-03-31 $87,897 30,520
2024-12-31 $161,040 34,264
2024-09-30 $91,045 25,503
2024-06-30 $155,744 25,120
2024-03-31 $3,653 387
2023-12-31 $2,571 381
2023-09-30 $1,602 361
2023-06-30 $3,184 965
2023-03-31 $27,832 9,766
2022-12-31 $23,259 3,195
2022-09-30 $44,922 5,553
2022-06-30 $28,761 5,870
2022-03-31 $332,352 14,053
2021-12-31 $403,649 22,818
2021-09-30 $165,281 5,859
2021-06-30 $83,127 7,932
2021-03-31 $110,129 9,349
2020-12-31 $220,521 18,832
2020-09-30 $117,680 14,840
2020-06-30 $279,800 15,298
2020-03-31 $108,916 9,122